Glaucoma screening with AI for diabetes patients
Part of Eyes & vision clinical trials.
This trial tests whether artificial intelligence can help find glaucoma early in people with diabetes who already get regular eye checks for diabetic eye disease. It may help catch glaucoma sooner without extra tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years or older
- You have diabetes (type 1 or type 2)
- You can have a photo taken of the back of your eye with a special camera
- You are willing to sign a consent form agreeing to join the study
- You are already getting eye screening through the diabetic retinopathy program at Singapore General Hospital or SingHealth Polyclinics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an artificial intelligence tool that may help detect glaucoma earlier. It compares AI analysis of eye images between people with glaucoma and healthy volunteers.
This trial uses an artificial intelligence (AI) program to screen for glaucoma in people who have a family history of the disease. It aims to catch glaucoma early, when it can be treated more effectively.
This trial uses an AI tool to screen for glaucoma at community health centers. If you qualify, you will get a free eye check to catch glaucoma early and help researchers improve screening for high-risk groups.
This study uses an AI-based system to check for diabetic retinopathy during regular eye exams at primary care clinics. It may help catch vision problems early if you have diabetes.
This study tests a new algorithm to help screen for glaucoma in people of African descent. It aims to improve early detection and diagnosis.
This trial uses artificial intelligence to analyze eye images and help doctors diagnose eye diseases. It looks at images from routine care to train and test the AI system.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.